Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > CNSE and Ultradian Diagnostics Partnership to Ramp up Research and Pilot Prototyping: Flexible, band aid-like patch for continuous glucose monitoring demonstrates great promise to enable pain-free treatment of people with diabetes

Abstract:
Ultradian Diagnostics LLC (Ultradian), an early-stage medical device company based in Rensselaer, New York, today announced the successful completion of a human pilot study for its minimally invasive, continuous glucose monitor (CGM), as well as the launch of advanced research and pilot prototyping in partnership with the College of Nanoscale Science and Engineering (CNSE) of the University at Albany - critical steps toward commercializing its innovative technology to deliver improved, pain-free treatment to individuals with diabetes.

CNSE and Ultradian Diagnostics Partnership to Ramp up Research and Pilot Prototyping: Flexible, band aid-like patch for continuous glucose monitoring demonstrates great promise to enable pain-free treatment of people with diabetes

Rensselaer, NY | Posted on December 19th, 2011

The human pilot study conducted at the State University of New York (SUNY) Upstate Medical University in Syracuse showed that Ultradian's Biologue CGM© - a flexible, band aid-like patch for real-time monitoring of blood glucose levels that would eliminate the need for painful pinpricks - exhibited a high degree of accuracy as compared to CGM devices now on the market.

The Biologue CGM© includes a skin-adhered sensor module that works in tandem with a small intradermal sensor, which measures glucose in interstitial fluid. The sensor module sends data up to 10 feet to a proprietary hand-held monitor or personal computer for display and analysis. The device is painless during use and no adverse skin reactions were observed.

Concurrently, Ultradian is now working with CNSE to accelerate the commercialization of its innovative health care technology. That collaboration, which integrates research at CNSE's Albany NanoTech Complex with access to pilot prototyping capabilities at CNSE's Smart System Technology and Commercialization Center of Excellence (STC) in Canandaigua, will enable top-quality, cost-effective scale-up for high-volume manufacturing.

"This is a major milestone on Ultradian's path toward commercialization that demonstrates our CGM is competitive in the marketplace for continuous glucose monitoring products," said Ultradian Diagnostics CEO John P. Willis, Ph.D. "Innovations in our CGM design that allow for real-time, automatic correction of signal drift due to bio-fouling, redundant glucose measurements and a single-point calibration method were successfully demonstrated in this study. The ability to partner with CNSE, including its Smart System Technology and Commercialization Center, is a critically important step forward in providing access to state-of-the-art capabilities that will accelerate commercialization at a fraction of the cost compared to similar companies at this stage of development."

"The partnership between Ultradian Diagnostics and CNSE's Smart System Technology and Commercialization Center of Excellence showcases CNSE's unique ability to provide a ‘one-stop shop' for advanced research and pilot prototyping that is critical to assisting small companies in commercializing their innovative products and creating high-tech jobs in New York," said Paul Tolley, CNSE Vice President for Disruptive Technologies and Director of CNSE's STC. "It also demonstrates the powerful potential of nanotechnology to drive 21st century health care technologies that offer improved performance at a reduced cost."

Ruth Weinstock, MD, Ph.D., Principal Investigator and Chief of Endocrinology, Diabetes and Metabolism at SUNY Upstate Medical University, said, "We are impressed with Ultradian's CGM and very excited by the results of this pilot study and believe this new technology could greatly benefit patients with diabetes, and move us forward in the development of the artificial pancreas."

Simultaneous with CGM measurements, two reference methods were utilized which included the YSI 2300 Stat Plus Glucose Analyzer for the analysis of venous blood samples and a One Touch Ultra Mini personal blood glucose meter for the analysis of fingerstick blood glucose samples and calibration. A total of 1023 paired data points were obtained. Using a standard accuracy metric known as the Clarke Error Grid, 87 percent of data fell within the clinically accurate "A" zone and 13 percent within the clinically acceptable "B" zone (100 percent). The mean absolute relative difference (MARD) was 11.4 percent, while the mean absolute residual (MAR) was 17.7 mg/dL.

Longer-term studies are planned with extended wear periods prior to FDA pre-market approval. Ultradian is actively pursuing strategic partnerships with established medical device companies to bring its technology to market and to close the loop to form an artificial pancreas.

####

About CNSE
The UAlbany CNSE is the first college in the world dedicated to education, research, development and deployment in the emerging disciplines of nanoscience, nanoengineering, nanobioscience and nanoeconomics. With more than $12 billon in high-tech investments, CNSE represents the world’s most advanced university-driven research enterprise, offering students a one-of-a-kind academic experience and providing over 300 corporate partners with access to an unmatched ecosystem for leading-edge R&D and commercialization of nanoelectronics and nanotechnology innovations. CNSE’s footprint spans upstate New York, including its Albany NanoTech Complex, an 800,000-square-foot megaplex with the only fully-integrated, 300mm wafer, computer chip pilot prototyping and demonstration line within 85,000 square feet of Class 1 capable cleanrooms. More than 2,600 scientists, researchers, engineers, students and faculty work here, from companies including IBM, Intel, GlobalFoundries, SEMATECH, Samsung, TSMC, Toshiba, Applied Materials, Tokyo Electron, ASML and Novellus Systems. An expansion now underway, part of which will house the world’s first Global 450mm Consortium, will add nearly 500,000 square feet of next-generation infrastructure, an additional 50,000 square feet of Class 1 capable cleanrooms, and more than 1,000 scientists, researchers and engineers from CNSE and global corporations. In addition, CNSE’s Solar Energy Development Center in Halfmoon provides a prototyping and demonstration line for next-generation CIGS thin-film solar cells. CNSE’s Smart Systems Technology and Commercialization Center of Excellence (STC) in Rochester offers state-of-the-art capabilities for MEMS fabrication and packaging. CNSE also co-founded and manages operations at the Computer Chip Commercialization Center at SUNYIT in Utica and is a co-founder of the Nanotechnology Innovation and Commercialization Excelerator in Syracuse.

About Ultradian Diagnostics LLC.

Ultradian is an early stage medical device company and a pioneer in the development of highly accurate minimally and non-invasive medical devices with applications in home health monitoring, intensive care and sports medicine.

For more information, please click here

Contacts:
John Willis
Chairman
CEO
Ultradian Diagnostics
518-618-0046


Steve Janack
Vice President
Marketing and Communications
CNSE
518-956-7322

Copyright © CNSE

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Strength of hair inspires new materials for body armor January 18th, 2017

Self-assembling particles brighten future of LED lighting January 18th, 2017

Dressing a metal in various colors: DGIST research developed a technology to coat metal with several nanometers of semiconducting materials January 17th, 2017

Nanoparticle exposure can awaken dormant viruses in the lungs January 17th, 2017

Nanomedicine

New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017

Keystone Nano Announces FDA Approval Of Investigational New Drug Application For Ceramide NanoLiposome For The Improved Treatment Of Cancer January 10th, 2017

Captured on video: DNA nanotubes build a bridge between 2 molecular posts: Research may lead to new lines of direct communication with cells January 9th, 2017

Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017

Announcements

Strength of hair inspires new materials for body armor January 18th, 2017

Self-assembling particles brighten future of LED lighting January 18th, 2017

Dressing a metal in various colors: DGIST research developed a technology to coat metal with several nanometers of semiconducting materials January 17th, 2017

Nanoparticle exposure can awaken dormant viruses in the lungs January 17th, 2017

Alliances/Trade associations/Partnerships/Distributorships

GLOBALFOUNDRIES Expands Partner Program to Speed Time-to-Market of FDX™ Solutions: Increased support affirms FDXcelerator™ Program’s vital role in promoting broader deployment of GLOBALFOUNDRIES’ FDX™ portfolio December 15th, 2016

Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016

Leti and Grenoble Partners Demonstrate World’s 1st Qubit Device Fabricated in CMOS Process: Paper by Leti, Inac and University of Grenoble Alpes Published in Nature Communications November 28th, 2016

Mechanism for sodium storage in 2-D material: Tin selenide is an effective host for storing sodium ions, making it a promising material for sodium ion batteries October 27th, 2016

Research partnerships

Chemistry on the edge: Experiments at Berkeley Lab confirm that structural defects at the periphery are key in catalyst function January 13th, 2017

Recreating conditions inside stars with compact lasers: Scientists offer a new path to creating the extreme conditions found in stars, using ultra-short laser pulses irradiating nanowires January 12th, 2017

Zeroing in on the true nature of fluids within nanocapillaries: While exploring the behavior of fluids at the nanoscale, a group of researchers at the French National Center for Scientific Research discovered a peculiar state of fluid mixtures contained in microscopic channels January 11th, 2017

New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project